Seven years after the activation of the prostate biopsy service using Fusion technology, one of the most advanced innovations ...

Profound is a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue.

Koelis, SAS (“Koelis” or the “Company”, a leader and innovator in MRI-ultrasound fusion guidance for prostate cancer interventions, recently announced that the Centers for Medicare & Medicaid ...

Profound Medical ( ($TSE:PRN) ) has shared an announcement. Profound Medical announced that The Johns Hopkins Hospital has performed its first ...

Accordingly, it is not surprising that a leading institution such as Johns Hopkins Medicine is at the forefront of this trend. John Hopkins University was an early participant in the clinical ...

RICHMOND, Va. (WRIC) — Virginia Commonwealth University’s (VCU) Massey Comprehensive Cancer Center in Richmond is the first site in Virginia to offer a new non-surgical robotic ultrasound procedure ...

Abstract: Under the guidance of high-resolution Magnetic Resonance Imaging (MRI), robotic devices offer a great advantage for prostate intervention. This paper presents an MR-safe robot, where a ...